Readers' responses to the article entitled "anticoagulation therapy for venous thromboembolism"
Hoyt, R.
MedGenMed Medscape general medicine 7(1): 49; author reply 48
2005
ISSN/ISBN: 1531-0132 PMID: 16369354 Document Number: 589099
Document emailed within 1 workday
Related Documents
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967Kind, H. 1976: Critical thoughts to the article by B. Staehelin "the development of a psychosomatic basis therapy entitled, the ftan meditation'" Schweizerische Rundschau für Medizin Praxis 65(27): 853
Prandoni, P.; Piovella, C.; Spiezia, L.; Dalla Valle, F.; Pesavento, R. 2011: Optimal duration of anticoagulation in patients with venous thromboembolism Indian Journal of Medical Research 134: 15-21
Farraj, R.S. 2004: Anticoagulation period in idiopathic venous thromboembolism. How long is enough? Saudi Medical Journal 25(7): 848-851
Poli, D.; Antonucci, E.; Ciuti, G.; Abbate, R.; Prisco, D. 2007: Anticoagulation quality and the risk of recurrence of venous thromboembolism Thrombosis and Haemostasis 98(5): 1148-1150
Abdel-Razeq, H.N.; Radwi, G.R. 2004: Duration of anticoagulation after first episode of unprovoked venous thromboembolism Saudi Medical Journal 25(11): 1776; Author Reply 1776-7
Marchetti, M.; Pistorio, A.; Barosi, G. 2000: Extended anticoagulation for prevention of recurrent venous thromboembolism in carriers of factor V Leiden--cost-effectiveness analysis Thrombosis and Haemostasis 84(5): 752-757
Burnayeva, S.V.; Vasilyeva, I.I.; Gavrisyuk, V.K.; Gerasimenko, S.I.; Gudz, I.M.; Dzyublik, A.Ya.; Dzyak, G.V.; Zharinov, O.I.; Kobza, I.I.; Kovalev, A.A.; Kolesnik, E.A.; Kostylev, M.V.; Kulik, I.V.; Lutay, Y.M.; Mishalov, V.G.; Mishchenko, T.S.; Nikonenko, A.S.; Nikonenko, A.A.; Nikulnikov, P.I.; Parkhomenko, A.N.; Polulyakh, M.V.; Rudenko, K.V.; Skupoy, O.M.; Tatarchuk, T.F.; Todurov, B.M.; Usenko, A.Yu.; Feshchenko, Y.I.; Chernukha, I.M.; Yachnik, A.I. 2017: The Experts Consensus for Anticoagulant Therapy of Venous Thromboembolism in 2016 Yr. Significance of the Rivaroxaban Investigations Program for Changes of Approaches, Concerning Treatment of the Deep Veins Thrombosis and Pulmonary Thromboembolism Klinichna Khirurhiia 2017(3): 65-80
Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
Spencer, F.A.; Gore, J.M.; Reed, G.; Lessard, D.; Pacifico, L.; Emery, C.; Crowther, M.A.; Goldberg, R.J. 2009: Venous thromboembolism and bleeding in a community setting. the Worcester Venous Thromboembolism Study Thrombosis and Haemostasis 101(5): 878-885
Betancourt, M.T.; Rodger, M.A. 2007: Risk stratification for recurrent venous thromboembolism in unprovoked venous thromboembolism patients Acta Chirurgica Belgica 107(6): 636-640
Granone, F. 1974: Hypnosis in medicine and psychology. On the merits of the article by Dr. Gulotta entitled "Ipnosi e psicologia: rimuginandoci" Minerva Medica 65(4): 205-208
Liu, F-fang.; Zhai, Z-guo.; Yang, Y-hua.; Wang, J.; Wang, C. 2013: Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism Zhonghua Yi Xue Za Zhi 93(24): 1860-1863
Emmerich, J.; Rosendaal, F.R.; Cattaneo, M.; Margaglione, M.; De Stefano, V.; Cumming, T.; Arruda, V.; Hillarp, A.; Reny, J.L. 2001: Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism Thrombosis and Haemostasis 86(3): 809-816
Lacut, K.; Oger, E. 2005: Hormone therapy and risk for venous thromboembolism in postmenopausal women La Revue du Praticien 55(4): 389-392
Pulanić, D. 2012: Venous thromboembolism, thrombophilia, and antithrombotic therapy in pregnancy in the light of the new guidelines Lijecnicki Vjesnik 134(7-8): 247-248
Lowe, G.; Rumley, A.; Woodward, M.; Vessey, M. 2000: C-reactive protein, idiopathic venous thromboembolism and hormone replacement therapy Thrombosis and Haemostasis 84(4): 730-731
Sarig, G.; Aberbach, I.; Schliamser, L.; Blumenfeld, Z.; Brenner, B. 2006: Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy Thrombosis and Haemostasis 96(5): 578-583
Mathew, P. 2006: Readers' responses to "where is physician leadership on reform?" MedGenMed: Medscape general medicine 8(2): 83; author reply 82
Walker, A.; Campbell, S.; Grimshaw, J. 1999: Implementation of a national guideline on prophylaxis of venous thromboembolism: a survey of acute services in Scotland. Thromboembolism Prevention Evaluation Study Group Health Bulletin 57(2): 141-147